Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Tests virtual care to aid recovery after heart failure hospital stays

Compares remote virtual heart failure care with routine care in adults after hospitalization.

Plain-language title generated from the registry record
Registry title: VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization

Key facts

Where
Hamilton, Thunder Bay, and Toronto, CanadaSee the 5 sites

Where in Canada

  • Hamilton General HospitalHamilton, CanadaTaking people
  • Juravinski Hospital Cancer CentreHamilton, CanadaTaking people
  • St. Joseph's Healthcare HamiltonHamilton, CanadaTaking people
  • Thunder Bay Regional Health Sciences CentreThunder Bay, CanadaNot yet recruiting
  • Unity Health TorontoToronto, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Population Health Research Institute
Trial code
NCT05724433
Record updated
7 August 2026
Original description
The clinic visits (intervention) will continue for 90 days, which represents the follow-up period for the primary medication and health status outcomes. The co-primary clinical outcomes will be obtained at 180 days.Read full original descriptionShow less

VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization (VICTORY-HF) RCT

The clinic visits (intervention) will continue for 90 days, which represents the follow-up period for the primary medication and health status outcomes. The co-primary clinical outcomes will be obtained at 180 days.

Inclusion: Adult patients ≥ 18 years old who:; Are being discharged after hospitalization or urgent visit for HF as; a primary diagnosis or; significant complication (prolonging length of stay) of another diagnosis OR Have been referred for an initial consult at a cardiology clinic within 1 week of hospitalization or urgent visit for HF as a primary or secondary diagnosis, as described above; Have left ventricular ejection fraction (LVEF) < 50% within the preceding 3 months; Have NT-proBNP of > 900 pg/ml during hospital admission or within 7 days after discharge from the ED; Have a mailing address for patient or caregiver; Provide verbal consent.

Exclusion: Receiving palliative care or expected life expectancy < 6 months; Unable to self-assess or communicate symptoms (e.g. clinically evident dementia); Severe valve disease; Recipient of or on waiting list for LVAD or cardiac transplant; Complex congenital heart disease, hypertrophic obstructive cardiomyopathy, or amyloid cardiomyopathy; Severe lung disease with symptoms on minimal exertion, forced expiratory volume during 1 second (FEV1) < 1 litre, severe pulmonary hypertension with RVSP > 60 mm Hg, or on home oxygen; Active malignancy; Severe kidney disease (persistent eGFR < 30 mL/min/1.73m2); Died or left hospital before medically advised hospital discharge; Unable to engage with digital health technology or follow up.

ClinicalTrials.gov NCT05724433